Imtiaz S, Nasir K, Drohlia MF, Salman B, Ahmad A (2016) Frequency of kidney diseases and clinical indications of pediatric renal biopsy: a single center experience. Indian J Nephrol 26:199–205

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ronkainen J, Ala-Houhala M, Autio-Harmainen H, Jahnukainen T, Koskimies O, Merenmies J et al (2006) Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study. Pediatr Nephrol 21:1266–1273

Article  PubMed  Google Scholar 

Wyatt RJ, Kritchevsky SB, Woodford SY, Miller PM, Roy S 3rd, Holland NH et al (1995) IgA nephropathy: long-term prognosis for pediatric patients. J Pediatr 127:913–919

Article  CAS  PubMed  Google Scholar 

Cambier A, Gleeson PJ, Flament H, Le Stang MB, Monteiro RC (2021) New therapeutic perspectives for IgA nephropathy in children. Pediatr Nephrol 36:497–506

Article  PubMed  Google Scholar 

Floege J, Rauen T, Tang SCW (2021) Current treatment of IgA nephropathy. Semin Immunopathol 43:717–728

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cambier A, Rabant M, Peuchmaur M, Hertig A, Deschenes G, Couchoud C et al (2018) Immunosuppressive treatment in children with IgA nephropathy and the clinical value of podocytopathic features. Kidney Int Rep 3:916–925

Article  PubMed  PubMed Central  Google Scholar 

Cambier A, Troyanov S, Tesar V, Coppo R, Validation Study of Oxford Classification (VALIGA) Group (2022) Indication for corticosteroids in IgA nephropathy: validation in the European VALIGA cohort of a treatment score based on the Oxford classification. Nephrol Dial Transplant 37:1195–1197

Article  Google Scholar 

Coppo R, Robert T (2020) IgA nephropathy in children and in adults: two separate entities or the same disease? J Nephrol 33:1219–1229

Article  PubMed  Google Scholar 

Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J et al (2020) TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy. Kidney Int 97:340–349

Article  CAS  PubMed  Google Scholar 

Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T et al (2008) Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 19:2384–2395

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torigoe M, Sakata K, Ishii A, Iwata S, Nakayamada S, Tanaka Y (2018) Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition. Clin Immunol 195:1–7

Article  CAS  PubMed  Google Scholar 

Cambier A, Neanne LL, Sahu S, Arbez L, Maillard N (2025) IgA nephropathy new therapies: from data in adults to application in children. Pediatr Nephrol. https://doi.org/10.1007/s00467-025-07004-9

Article  PubMed  Google Scholar 

Gao R, Wu W, Wen Y, Li X (2017) Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy. Int Urol Nephrol 49:1233–1241

Article  CAS  PubMed  Google Scholar 

Yang YZ, Chen P, Liu LJ, Cai QQ, Shi SF, Chen YQ et al (2019) Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study. BMC Nephrol 20:297

Article  PubMed  PubMed Central  Google Scholar 

Tang C, Lv JC, Shi SF, Chen YQ, Liu LJ, Zhang H (2020) Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study. BMC Nephrol 21:469

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN et al (2019) Effects of hydroxychloroquine on proteinuria in IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 74:15–22

Article  CAS  PubMed  Google Scholar 

Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA et al (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637

Article  PubMed  PubMed Central  Google Scholar 

Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M et al (2017) Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int 91:1014–1021

Article  PubMed  Google Scholar 

KDIGO (2021) Clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1-s276

Article  Google Scholar 

Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN et al (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78:736–745

Article  CAS  PubMed  Google Scholar 

KDIGO (2024) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105:S117-s314

Article  Google Scholar 

Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S et al (2024) Are children with IgA nephropathy different from adult patients? Pediatr Nephrol 39:2403–2412

Article  PubMed  PubMed Central  Google Scholar 

Yoshikawa N, Iijima K, Matsuyama S, Suzuki J, Kameda A, Okada S et al (1990) Repeat renal biopsy in children with IgA nephropathy. Clin Nephrol 33:160–167

CAS  PubMed  Google Scholar 

Kawasaki Y, Maeda R, Kanno S, Suzuki Y, Ohara S, Suyama K et al (2017) Long-term follow up of pediatric immunoglobulin A nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy. Pediatr Int 59:41–47

Article  CAS  PubMed  Google Scholar 

Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D et al (2025) IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol 40:533–569

Article  PubMed  Google Scholar 

Cambier A, Dossier C, Lapeyraque A-L, Phan V, Laroche C, Abukasm K et al (2025) Bridging pediatric and adult IgAN: challenges in applying proteinuria-driven recommendations in the new IPNA guidelines. Pediatr Nephrol 40:2107–2111

Article  PubMed  Google Scholar 

Haas M, Cambier A (2025) IPNA recommendations for treatment of IgA nephropathy: why there should be a greater emphasis on pathology moving forward. Pediatr Nephrol 40:2411

Article  PubMed  Google Scholar